Australia markets close in 1 hour 42 minutes

Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
38.75+0.66 (+1.73%)
As of 12:14PM CST. Market open.
Currency in CNY

Valuation measures4

Market cap (intra-day) 13.15B
Enterprise value 12.88B
Trailing P/E 31.48
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.71
Price/book (mrq)6.24
Enterprise value/revenue 4.63
Enterprise value/EBITDA 27.00

Trading information

Stock price history

Beta (5Y monthly) 0.48
52-week change 352.36%
S&P500 52-week change 324.49%
52-week high 339.00
52-week low 318.80
50-day moving average 335.74
200-day moving average 329.20

Share statistics

Avg vol (3-month) 33.15M
Avg vol (10-day) 33.77M
Shares outstanding 5345.15M
Implied shares outstanding 6345.15M
Float 8174.39M
% held by insiders 151.28%
% held by institutions 116.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.24
Forward annual dividend yield 40.62%
Trailing annual dividend rate 30.32
Trailing annual dividend yield 30.84%
5-year average dividend yield 40.54
Payout ratio 419.50%
Dividend date 3N/A
Ex-dividend date 415 May 2023
Last split factor 21.4:1
Last split date 327 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.99%
Operating margin (ttm)25.94%

Management effectiveness

Return on assets (ttm)10.25%
Return on equity (ttm)22.25%

Income statement

Revenue (ttm)2.78B
Revenue per share (ttm)8.08
Quarterly revenue growth (yoy)17.70%
Gross profit (ttm)N/A
EBITDA 514.24M
Net income avi to common (ttm)417.04M
Diluted EPS (ttm)1.21
Quarterly earnings growth (yoy)63.40%

Balance sheet

Total cash (mrq)655.36M
Total cash per share (mrq)1.9
Total debt (mrq)386.58M
Total debt/equity (mrq)18.35%
Current ratio (mrq)4.15
Book value per share (mrq)6.10

Cash flow statement

Operating cash flow (ttm)571.13M
Levered free cash flow (ttm)-78.49M